Sulforaphane inhibits hepatic steatosis in rats by down-regulating DGAT2 and ACAT1 expression

Sicong TIAN; Peng LEI; Yao SUN; Xiuli YANG; Yujuan SHAN; Baolong LI

doi:10.16016/j.1000-5404.201812039

您当前的位置：

首页 >

文章列表页 >

Sulforaphane inhibits hepatic steatosis in rats by down-regulating DGAT2 and ACAT1 expression

Basic Medicine | 更新时间：2026-01-09

- Sulforaphane inhibits hepatic steatosis in rats by down-regulating DGAT2 and ACAT1 expression
- Journal of Third Military Medical University Vol. 41, Issue 12, Pages: 1102-1109(2019)
- 作者机构：
  
  1.150001 哈尔滨, 哈尔滨工业大学化工与化学学院食品科学与工程系
  2.150040 哈尔滨, 黑龙江中医药大学药物安全评价中心
- 作者简介：
- 基金信息：
  
  Suported by the General Program of National Natural Science Foundation of China(81573135)
- DOI：10.16016/j.1000-5404.201812039
  CLC： R575.5;R589.2;R965
- Received：05 December 2018，
  
  Revised：2019-02-12，
  
  Published：30 June 2019
- 稿件说明：
移动端阅览
Sicong TIAN, Peng LEI, Yao SUN, et al. Sulforaphane inhibits hepatic steatosis in rats by down-regulating DGAT2 and ACAT1 expression[J]. Journal of Third Military Medical University, 2019, 41(12): 1102-1109.
DOI：

Sicong TIAN, Peng LEI, Yao SUN, et al. Sulforaphane inhibits hepatic steatosis in rats by down-regulating DGAT2 and ACAT1 expression[J]. Journal of Third Military Medical University, 2019, 41(12): 1102-1109. DOI： 10.16016/j.1000-5404.201812039.

摘要

目的

研究莱菔硫烷(sulforaphane，SFN)对脂肪滴和脂滴外周蛋白的影响，阐明莱菔硫烷抑制高脂摄入引起的非酒精性脂肪肝的作用机制。

方法

建立高脂膳食诱导大鼠肝脏脂肪变性模型，用莱菔硫烷干预。根据体质量将60只雄性

Wistar大鼠按随机数表法分为6组(

=10)：正常食物组、高脂饲料组、高脂饲料+高剂量莱菔硫烷(20 mg/kg)处理组、高脂饲料+中剂量莱菔硫烷(10 mg/kg)处理组、高脂饲料+低剂量莱菔硫烷(5 mg/kg)处理组和高脂饲料+阳性药物(30 mg/kg)组。检测各组大鼠肝组织中甘油三酯和总胆固醇的含量，采用油红O染色观察大鼠肝脏内脂滴形态；Western blot检测大鼠肝脏中甘油三酯和胆固醇的关键合成酶DGAT2和ACAT1蛋白的表达；免疫组化和实时定量PCR检测脂滴外周蛋白PLIN1、PLIN2、PLIN3和PLIN5的表达。

结果

莱菔硫烷能够减轻高脂饲料引起的大鼠体质量的增加，降低大鼠肝脏内甘油三酯和总胆固醇的含量，减少脂肪滴积累，缩小脂肪滴体积。各剂量莱菔硫烷均显著下调大鼠肝脏中DGAT2和ACAT1蛋白的表达(

0.01)。高剂量莱菔硫烷组大鼠肝组织中PLIN2、PLIN5 mRNA和蛋白表达明显下调(

0.01，

0.05)。

结论

莱菔硫烷可以通过降低大鼠肝组织中DGAT2、ACAT1的表达以及脂滴外周蛋白PLIN2、PLIN5的表达，抑制脂滴的生成。

Abstract

Objective

To study the effects of sulforaphane (SFN) on the deposition of lipid droplets and the expression of their peripheral proteins in the liver and elucidate the mechanism by which SFN inhibits non-alcoholic fatty liver caused by high-fat diet.

Methods

Sixty male Wistar rats were randomized into 6 equal groups (

=10)

including

normal food group

high-fat diet group

3 high-fat diet groups treated with high (20 mg/kg)

moderate (10 mg/kg) and low (5 mg/kg) doses of SFN

and

high-fat diet group treated with

positive drug (30 mg/kg). Triglyceride and total cholesterol contents were examined and the deposition of lipid droplets in the liver was detected with oil red

staining in all the rats. The protein expression of DGAT2 and ACAT1 (the key synthases of triglyceride and cholesterol

respectively) in the liver tissues were detected with Western blotting; immunohistochemistry and real-time PCR were performed to examine the expression of the PAT proteins (PLIN1

PLIN2

PLIN3 and PLIN5) at both the protein and mRNA levels in the liver.

Results

SFN treatment obviously reduced high-fat diet-induced bodyweight g

ain in the rats

lowered the levels of triglyceride and total cholesterol

lessened lipid droplet deposition in the liver and reduced the volume of the lipid droplets. Treatment with SFN at all the 3 doses significantly down-regulated the expression of ACAT1 and DGAT2 in the liver of the rats (

0.01). SFN at the high doses significantly down-regulated the expression of PLIN2 and PLIN5 in liver tissue at both the mRNA and protein levels (

0.01

0.05).

Conclusion

SFN can inhibit the formation of lipid droplets by reducing the expressions of DGAT2

ACAT1

PLIN2 and PLIN5 in the liver of rats.

关键词

Keywords

references

FRIEDMAN S L, NEUSCHWANDER-TETRI B A, RINELLA M, et al. Mechanisms of NAFLD development and therapeutic strategies[J]. Nat Med, 2018, 24(7): 908-922. DOI: 10.1038/s41591-018-0104-9.

付丽娜, 张秋瓒.非酒精性脂肪性肝病治疗进展[J].实用医学杂志, 2017, 33(13): 2075-2078. DOI: 10.3969/j.issn.1006-5725.2017.13.002.

FU L N, ZHANG Q Z. Progress in the treatment of nonalcoholic fatty liver disease[J]. J Pract Med, 2017, 33(13): 2075-2078. DOI: 10.3969/j.issn. 1006-5725.2017.13.002.

GLUCHOWSKI N L, BECUWE M, WALTHER T C, et al. Lipid droplets and liver disease: from basic biology to clinical implications[J]. Nat Rev Gastroenterol Hepatol, 2017, 14(6): 343-355. DOI: 10.1038/nrgastro.2017.32.

ZHANG J C, YAO W, DONG C, et al. Prophylactic effects of sulforaphane on depression-like behavior and dendritic changes in mice after inflammation[J]. J Nutr Biochem, 2017, 39: 134-144. DOI: 10.1016/j.jnutbio.2016.10.004.

CHOI K M, LEE Y S, KIM W, et al. Sulforaphane attenuates obesity by inhibiting adipogenesis and activating the AMPK pathway in obese mice[J]. J Nutr Biochem, 2014, 25(2): 201-207. DOI: 10.1016/j.jnutbio.2013.10.007.

ZHANG H Q, CHEN S Y, WANG A S, et al. Sulforaphane induces adipocyte browning and promotes glucose and lipid utilization[J]. Mol Nutr Food Res, 2016, 60(10): 2185-2197. DOI: 10.1002/mnfr.201500915.

HARRIS C A, HAAS J T, STREEPERR S, et al. DGAT enzymes are required for triacylglycerol synthesis and lipid droplets in adipocytes[J]. J Lipid Res, 2011, 52(4): 657-667. DOI: 10.1194/jlr.M013003.

ZHU Y Y, CHEN C Y, LI J J, et al. In vitro exploration of ACAT contributions to lipid droplet formation during adipogenesis[J ] . J Lipid Res, 2018, 59(5): 820-829. DOI: 10.1194/jlr.M081745.

PLOEN D, HAFIRASSOU M L, HIMMELSBACH K, et al.TIP47 is associated with the hepatitis C virus and its interaction with Rab9 is required for release of viral particles[J]. Eur J Cell Biol, 2013, 92(12): 374-382. DOI: 10.1016/j.ejcb.2013.12.003.

SZTALRYD C, KIMMEL A R. Perilipins: lipid droplet coat proteins adapted for tissue-specific energy storage and utilization, and lipid cytoprotection[J]. Biochimie, 2014, 96: 96-101. DOI: 10.1016/j.biochi.2013.08.026.

MANE D R, KALE A D, BELALDAVAR C. Validation of immunoexpression of tenascin-C in oral precancerous and cancerous tissues usingImageJ analysis with novel immunohistochemistry profiler plugin: an immunohistochemical quantitative analysis[J]. J Oral Maxillofac Pathol, 2017, 21(2): 211-217. DOI: 10.4103/jomfp.JOMFP_234_16.

MIRMIRAN P, BAHADORAN Z, GOLZARAND M, et al. Association between dietary phytochemical index and 3-year changes in weight, waist circumference and body adiposity index in adults: tehran lipid and glucose study[J]. NutrMetab (Lond), 2012, 9(1): 108. DOI: 10.1186/1743-7075-9-108.

BAEK S H, PARK M, SUH J H, et al. Protective effects of an extract of young radish (Raphanus sativus L) cultivated with sulfur (sulfur-radish extract) and of sulforaphane on carbon tetrachloride-induced hepatotoxicity[J]. Biosci Biotechnol Biochem, 2008, 72(5): 1176-1182. DOI: 10. 1271/bbb.70545.

李宝龙, 田思聪, 谭洁, 等.绿花椰菜片剂中莱菔硫烷含量测定及对急性酒精性肝损伤的保护作用[J].浙江大学学报(农业与生命科学版), 2013, 39(2): 197-202. DOI: 10.3785/j.issn.1008-9209.2012.11.613.

LI B L, TIAN S C, TAN J, et al. Quantitative determination of sulforaphane from broccoli extract tablets and its role in the protection of acute liver injury induced by ethanol[J]. J Zhejiang Univ(Agr Life Sci), 2013, 39(2): 197-202. DOI: 10.3785/j.issn.1008-9209.2012.11.613.

HUNG Y H, CARREIRO A L, BUHMAN K K. Dgat1 and Dgat2 regulate enterocyte triacylglycerol distribution and alter proteins associated with cytoplasmic lipid droplets in response to dietary fat[J]. Biochim Biophys Acta Mol Cell Biol Lipids, 2017, 1862(6): 600-614. DOI: 10.1016/j.bbalip.2017.02.014.

YANG W, BAI Y B, XIONG Y, et al. Potentiating the antitumour response of CD8(+) T cells by modulating cholesterol metabolism[J]. Nature, 2016, 531(7596): 651-655. DOI: 10.1038/nature17412.

MCMANAMAN J L, BALES E S, ORLICKY D J, et al. Perilipin-2-null mice are protected against diet-induced obesity, adipose inflammation, and fatty liver disease[J]. J Lipid Res, 2013, 54(5): 1346-1359. DOI: 10.1194/jlr.M035063.

FENG Y Z, LUND J, LI Y C, et al. Loss of perilipin 2 in cultured myotubes enhances lipolysis and redirects the metabolic energy balance from glucose oxidation towards fatty acid oxidation[J]. J Lipid Res, 2017, 58(11): 2147-2161. DOI: 10.1194/jlr.M079764.

LAURENS C, BOURLIER V, MAIRAL A, et al. Perilipin 5 fine-tunes lipid oxidation to metabolic demand and protects against lipotoxicity in skeletal muscle[J]. Sci Rep, 2016, 6: 38310. DOI: 10.1038/srep38310.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Serum triglyceride levels are associated with the severity and prognosis of acute pancreatitis

Effect of sulforaphane on antioxidant capacity and mitochondrial function of hepatocytes in vitro and in rats with hepatic oxidative stress

GLP-1(7-36) inhibits atherosclerosis progression in ApoE-/- mouse aorta by lowering expressions of CD36 and ACAT1 in foam cells

Sulforaphane inhibits astrocyte proliferation by induced LPS in mice

Effect of sulforaphane on hindlimb function after spinal cord injury in mice

Related Author

Shengyu Deng

Xing Chang

Xin Yang

Shiming Yang

Xianlong Ling

Baolong LI

Yao SUN

Chunying TENG

Related Institution

Department of Gastroenterology, Xinqiao Hospital, Third Military Medical University

Center of Drug Safety and Evaluation, Heilongjiang University of Chinese Medicine

⁰